Difficulties of smoking cessation in diabetic inpatients benefiting from a systematic consultation to help them to give up smoking

Diabetes and Metabolism

Volumn 32, Issue 5, 2006, Pages 435-441

  Scemama, O ^a,b,d   Hamo Tchatchouang, E ^a,b   Le Faou, A L ^a,c   Altman, J J ^a,b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Diabetes; Hospital; Nicotine dependence; Smoking cessation

Indexed keywords

NICOTINE;

ADULT; ARTICLE; CIGARETTE SMOKING; CONSULTATION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DRUG DEPENDENCE; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; SMOKING CESSATION; TOBACCO DEPENDENCE;

EID: 33751528264     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70301-4     Document Type: Article

References (42)

1. Hill C, Laplanche A. Tabagisme et mortalité: aspects épidémiologiques. BEH 2003;22-23:98-100.
2. Haire-Joshu D, Glasgow RE, Tibbs TL. Smoking and diabetes. Diabetes Care 1999;22:1887-98.
3. Ritz E, Ogata H, Orth SR. Smoking: a factor promoting onset and progression of diabetic nephropathy. Diabetes Metab 2000;26 Suppl 4:54-63.
4. Muhlhauser I, Bender R, Bott U, et al. Cigarette smoking and progression of retinopathy and nephropathy in type 1 diabetes. Diabet Med 1996;13:536-43.
5. American Diabetes Association. Smoking and diabetes. Diabetes Care 2004;27 (Suppl. 1):S74-S75.
6. 1c values and microalbuminuria in patients with diabetes-data from the National Diabetes Register in Sweden. Diabetes Metab 2004;30:261-8.
7. Hadden DR, Patterson CC, Atkinson AB, et al. Macrovascular disease and hyperglycaemia: 10-year survival analysis in Type 2 diabetes mellitus: the Belfast Diet Study. Diabet Med 1997;14:663-72.
8. Schernthaner G. Cardiovascular mortality and morbidity in type-2 diabetes mellitus. Diabetes Res Clin Pract 1996;31 (Suppl.):S3-S13.
9. Ford ES, Mokdad AH, Gregg EW. Trends in cigarette smoking among US adults with diabetes: findings from the Behavioral Risk Factor Surveillance System. Prev Med 2004;39:1238-42.
10. Colhoun HM, Dong W, Barakat MT, Mather HM, Poulter NR. The scope for cardiovascular disease risk factor intervention among people with diabetes mellitus in England: a population-based analysis from the Health Surveys for England 1991-94. Diabet Med 1999;16:35-40.
11. Agence Nationale d'Accréditation et d'Evaluation en Santé. Stratégie de prise en charge du patient diabétique du type 2 à l'exclusion de la prise en charge des complications. Paris: ANAES, 2000. http://www.anaes.fr
12. Chaturvedi N, Stevens L, Fuller JH. Which features of smoking determine mortality risk in former cigarette smokers with diabetes? The World Health Organization Multinational Study Group. Diabetes Care 1997;20:1266-72.
13. Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco use and Dependence - Clinical Practice Guideline. Rockville: U.S. Department of Health and Human Services. Public Health Service, 2000. www.surgeongeneral.gov/tobacco/default. htm
14. Haire-Joshu D. Smoking, cessation, and the diabetes health care team. Diabetes Educ 1991;17:54-64.
15. Sawicki PT, Didjurgeit U, Muhlhauser I, Berger M. Behaviour therapy versus doctor's anti-smoking advice in diabetic patients. J Intern Med 1993;234:407-9.
16. Institut National de Prévention et d'Éducation pour la Santé (INPES). Dossier Consultation de tabacologie. Paris, 2001. http://www.inpes.sante.fr/10000/dosstabaco/pdf/Dossier_de_tabacologie.pdf
17. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991;86:1119-27.
18. Zigmond AS, Snaith RP. The Hospital Anxiety and depression Scale. Acta Psychiatr Scand 1983;67:361-70.
19. Canga N, De Irala J, Vara E, Duaso MJ, Ferrer A, Martinez-Gonzalez MA. Intervention study for smoking cessation in diabetic patients: a randomized controlled trial in both clinical and primary care settings. Diabetes Care 2000;23:1455-60.
20. Oddoux K, Peretti-Watel P, Baudier F. Tabac. In Guilbert P, Baudier F, Gautier A (sous la direction de), eds. Baromètre Santé 2000 "Résultats". Paris: Editions CFES 2001: 77-122.
21. Charpentier G, Genes N, Vaur L, et al. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey. Diabetes Metab 2003;29:152-8.
22. Solberg LI, Desai JR, O'Connor PJ, Bishop DB, Devlin HM. Diabetic patients who smoke: are they different? Ann Fam Med 2004;2:26-32.
23. Egede LE, Zheng D. Independent factors associated with major depressive disorder in a national sample of individuals with diabetes. Diabetes Care 2003;26:104-11.
24. Katon W, von Korff M, Ciechanowski P, et al. Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care 2004;27:914-20.
25. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24:1069-78.
26. Lagrue G, Légeron P, Azoulay S, Pelissolo S, Aubin HJ, Humbert R. Élaboration d'un test permettant d'évaluer la motivation à l'arrêt du tabac. Alcoologie et Addictologie 2002;24:33-7.
27. Wakefield M, Roberts L, Rosenfeld E. Prospects for smoking cessation among people with insulin-dependent diabetes. Patient Educ Couns 1998;34:257-66.
28. Haire-Joshu D, Heady S, Thomas L, Schechtman K, Fisher EB Jr. Beliefs about smoking and diabetes care. Diabetes Educ 1994;20:410-5.
29. Haire-Joshu D, Ziff S, Houston C. The feasibility of recruiting hospitalized patients with diabetes for a smoking cessation program. Diabetes Educ 1995;21:214-8.
30. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 1983;51:390-5.
31. Agence Française de Sécurité Sanitaire des Produits de Santé. Les stratégies thérapeutiques médicamenteuses et non médicamenteuses de l'aide à l'arrêt du tabac - Recommandations. Saint-Denis : AFSSAPS, Mai 2003, 39 p. http://agmed.sante.gouv.fr/pdf/5/rbp/tabreco.pdf
32. Fava JL, Velicer WF, Prochaska JO. Applying the transtheoretical model to a representative sample of smokers. Addict Behav 1995;20:189-203.
33. Pollak KI, Carbonari JP, DiClemente CC, Niemann YF, Mullen PD. Causal relationships of processes of change and decisional balance: stage-specific models for smoking. Addict Behav 1998;23:437-48.
34. Ruggiero L, Rossi JS, Prochaska JO, et al. Smoking and diabetes: readiness for change and provider advice. Addict Behav 1999;24:573-8.
35. Kim O, Kim JH, Jung JH. Stress and cigarette smoking in Korean men with diabetes. Addict Behav 2006;31:478-86.
36. Prochaska JO, Goldstein MG. Process of smoking cessation. Implications for clinicians. Clin Chest Med 1991;12:727-35.
37. Prochaska JO. Strong and weak principles for progressing from precontemplation to action on the basis of twelve problem behaviors. Health Psychol 1994;13:47-51.
38. Miller W, Rollnick S. Preparing people for change. New york, Guilford Press, 2002.
39. Emmons KM, Rollnick S. Motivational interviewing in health care settings. Opportunities and limitations. Am J Prev Med 2001;20:68-74.
40. Gill GV, Morgan C, MacFarlane IA. Awareness and use of smoking cessation treatments among diabetic patients. Diabet Med 2005;22:658-60.
41. Cox SL. Rimonabant hydrochloride: an investigational agent for the management of cardiovascular risk factors. Drugs Today (Barc) 2005;41:499-508.
42. Kirkman MS, Weinberger M, Landsman PB, et al. A telephonedelivered intervention for patients with NIDDM. Effect on coronary risk factors. Diabetes Care 1994;17:840-6.